Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

NCT06461351 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Tumors

Interventions

OTHER: Inaticabtagene autoleucel Injection

Sponsor

Juventas Cell Therapy Ltd.